OR FILL OUT THIS FORM AND A COUNSELOR WILL GET BACK TO YOU TO ANSWER YOUR QUESTIONS AND HELP YOU LOCATE A DRUG TREATMENT PROGRAM THAT FITS YOUR PARTICULAR NEEDS.
Information Provided By:
Drug Rehab Programs That Offer Hospital Inpatient Services category listings in Garryowen, Montana:
Sheridan VA Healthcare System (51.8 miles from Garryowen, Montana)
Sheridan VA Healthcare System is located at:
1898 Fort Road Sheridan, WY. 82801 307-672-3473
Treatment Services: Hospital Inpatient, Outpatient, Persons With Co-Occurring Mental And Substance Abuse Disorders, Persons With Hiv/Aids, Gays And Lesbians, Seniors/Older Adults, Criminal Justice Clients, ASL Or Other Assistance For Hearing Impaired Payment Options: Self Payment, State Financed Insurance (Other Than Medicaid), Private Health Insurance, Military Insurance (E.G., Va, Tricare)
Rimrock Foundation (55.9 miles from Garryowen, Montana)
Rimrock Foundation is located at:
1231 North 29th Street Billings, MT. 59101 406-248-3175
Treatment Services: Substance Abuse Treatment Services, Hospital Inpatient, Outpatient, Adolescents, Persons With Co-Occurring Mental And Substance Abuse Disorders, Women, Men, Dui/Dwi Offenders Payment Options: Self Payment, Medicaid, State Financed Insurance (Other Than Medicaid), Private Health Insurance
Dangerous side effects of meth use include an elevated body temperature, skin ulcerations and infections, paranoia, depression, and permanent damage to brain cells.
Meth users who inject the drug are at risk of developing damaged blood vessels and skin abscesses.
When a person is on meth their behavior often changes. They may be easily agitated, feel wired, act unpredictably and do this repetitiously.
Recently, meth has a new look and taste as meth cooks are now adding coloring and flavoring to the drug. Experts believe people between ages 18 to 25 are the most likely to use flavored forms of meth.
Habitual meth abuse will lead to addictiona chronic problem characterized by compulsive drug seeking and use, which is accompanied by chemical and molecular changes in the users brain.